Cargando…

Drug-targeting by monoclonal antibodies.

Detalles Bibliográficos
Autor principal:	Embleton, M. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1987
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001752/ https://www.ncbi.nlm.nih.gov/pubmed/3552013

Ejemplares similares

Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
por: Affleck, K., et al.
Publicado: (1992)

Genes and antigens in cancer cells - The monoclonal antibody approach
por: Embleton, M.J.
Publicado: (1984)

Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugate.
por: Embleton, M. J., et al.
Publicado: (1984)

Reactivity of monoclonal antibodies to oncoproteins with normal rat liver, carcinogen-induced tumours, and premalignant liver lesions.
por: Embleton, M. J., et al.
Publicado: (1988)

Antitumour reactions of monoclonal antibody against a human osteogenic-sarcoma cell line.
por: Embleton, M. J., et al.
Publicado: (1981)

Selective cytotoxicity against human tumour cells by a vindesine-monoclonal antibody conjugate.
por: Embleton, M. J., et al.
Publicado: (1983)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Cancer Surveys—Experimental approach to drug targeting
por: Embleton, M.J.
Publicado: (1983)

Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
por: Radocha, Jakub, et al.
Publicado: (2021)

Monoclonal antibodies targeting CD20
por: Chang, Chien-Hsing, et al.
Publicado: (2013)

A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate.
por: Pimm, M. V., et al.
Publicado: (1990)

Binding of omeprazole to protein targets identified by monoclonal antibodies
por: Cartee, Naw May Pearl, et al.
Publicado: (2020)

Current and emerging monoclonal antibodies, antibody-drug conjugates, and bispecific antibodies in treatment of lymphoma
por: Atallah-Yunes, Suheil Albert, et al.
Publicado: (2022)

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates
por: Albarrán, Víctor, et al.
Publicado: (2022)

Melanoma antigens and antibodies
por: Embleton, M.J.
Publicado: (1983)

Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain.
por: Embleton, M. J., et al.
Publicado: (1991)

Model-Based Assessment of Dosing Strategies in Children for Monoclonal Antibodies Exhibiting Target-Mediated Drug Disposition
por: Zheng, S, et al.
Publicado: (2014)

Response to: Monoclonal antibodies targeting CD20
por: Klein, Christian, et al.
Publicado: (2013)

Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates.
por: Durrant, L. G., et al.
Publicado: (1987)

Effects of a novel Nodal-targeting monoclonal antibody in melanoma
por: Strizzi, Luigi, et al.
Publicado: (2015)

Tumor Targeting by Monoclonal Antibody Functionalized Magnetic Nanoparticles
por: Oltolina, Francesca, et al.
Publicado: (2019)

Role of monoclonal antibody drugs in the treatment of COVID-19
por: Ucciferri, Claudio, et al.
Publicado: (2020)

Target Therapy in Hematological Malignances: New Monoclonal Antibodies
por: Podhorecka, Monika, et al.
Publicado: (2014)

Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer
por: Wathoni, Nasrul, et al.
Publicado: (2022)

Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
por: van de Donk, Niels W. C. J., et al.
Publicado: (2016)

Tregalizumab – A Monoclonal Antibody to Target Regulatory T Cells
por: König, Martin, et al.
Publicado: (2016)

Monoclonal Antibodies Targeting Ion Channels and Their Therapeutic Potential
por: Haustrate, Aurélien, et al.
Publicado: (2019)

Novel monoclonal antibodies targeting the microtubule-binding domain of human tau
por: Croft, Cara L., et al.
Publicado: (2018)

Therapeutic use of monoclonal antibodies: general aspects and challenges for drug delivery
por: Quinteros, Daniela A., et al.
Publicado: (2017)

Monoclonal Antibodies to the Thyrotropin Receptor
por: Ando, Takao, et al.
Publicado: (2005)

Monoclonal antibodies for imaging and therapy.
por: Epenetos, A. A., et al.
Publicado: (1989)

Multifunctional Monoclonal Antibody Targeting Pseudomonas aeruginosa Keratitis in Mice
por: Hebert, Wesley, et al.
Publicado: (2020)

Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments
por: Chi, Xiao-Kai, et al.
Publicado: (2023)

CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
por: Vandervorst, Fenne, et al.
Publicado: (2021)

Human monoclonal antibodies to glioma cells.
por: Sikora, K., et al.
Publicado: (1981)

Xenogeneic monoclonal antibodies in the management of cancer: control of their in vivo immunogenicity and induction of specific unresponsiveness using an antibody-drug immunoconjugate.
por: Sivolapenko, G. B., et al.
Publicado: (1991)

Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets
por: Wattenberg, M M, et al.
Publicado: (2014)

Intratibial injection of an anti-doxorubicin monoclonal antibody prevents drug-induced myelotoxicity in mice.
por: Morelli, D., et al.
Publicado: (1997)

Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells
por: Saha, Nayanendu, et al.
Publicado: (2021)

Fc-engineered monoclonal antibodies to reduce off-target liver uptake
por: Mangeat, Tristan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h12psb3o7eckp3b31sqbil64ui